Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Neoplasms 6Pain 3Burns 2Breakthrough Pain 2Anemia, Sickle Cell 2Agnosia 2Pain, Postoperative 1Pain, Intractable 1Lung Neoplasms 1Intrathecal Dexmedetomidine 1Dyspnea, Paroxysmal 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Bone Metastases 1

Interventions

Ropivacaine 2Magnesium Sulfate 2Fentanyl 2trimebutine 3-thiocarbamoylbenzenesulfonate 1ramosetron 1Transdermal Patch 1Tablets 1Surveys and Questionnaires 1Psilocybin 1Pregabalin 1Nefopam 1Morphine 1Lidocaine 1Levobupivacaine 1Ketoprofen 1Ketamine 1Injections, Subcutaneous 1High-Energy Shock Waves 1Control Groups 1Capsaicin 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthetics, Local 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Fentanyl × Clear all
NCT01703351 2019-01-31

Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy

Yonsei University

Phase 2 Completed
79 enrolled
Thoracic

Agnosia, Lung Neoplasms, Pain, Postoperative

NCT00236041 2014-05-09

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Completed
38 enrolled
Classical hematology

Agnosia, Anemia, Sickle Cell, Burns, Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡